These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1070 related articles for article (PubMed ID: 26802132)

  • 1. A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223.
    Wang K; Long B; Liu F; Wang JX; Liu CY; Zhao B; Zhou LY; Sun T; Wang M; Yu T; Gong Y; Liu J; Dong YH; Li N; Li PF
    Eur Heart J; 2016 Sep; 37(33):2602-11. PubMed ID: 26802132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489.
    Wang K; Liu F; Zhou LY; Long B; Yuan SM; Wang Y; Liu CY; Sun T; Zhang XJ; Li PF
    Circ Res; 2014 Apr; 114(9):1377-88. PubMed ID: 24557880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the highly abundant circular RNA circSlc8a1 in cardiomyocytes attenuates pressure overload induced hypertrophy.
    Lim TB; Aliwarga E; Luu TDA; Li YP; Ng SL; Annadoray L; Sian S; Ackers-Johnson MA; Foo RS
    Cardiovasc Res; 2019 Dec; 115(14):1998-2007. PubMed ID: 31114845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy.
    Seok HY; Chen J; Kataoka M; Huang ZP; Ding J; Yan J; Hu X; Wang DZ
    Circ Res; 2014 May; 114(10):1585-95. PubMed ID: 24657879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
    Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
    Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-328 as a regulator of cardiac hypertrophy.
    Li C; Li X; Gao X; Zhang R; Zhang Y; Liang H; Xu C; Du W; Zhang Y; Liu X; Ma N; Xu Z; Wang L; Chen X; Lu Y; Ju J; Yang B; Shan H
    Int J Cardiol; 2014 May; 173(2):268-76. PubMed ID: 24631114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
    Li Q; Xie J; Wang B; Li R; Bai J; Ding L; Gu R; Wang L; Xu B
    PLoS One; 2016; 11(2):e0148480. PubMed ID: 26914935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-106a promotes cardiac hypertrophy by targeting mitofusin 2.
    Guan X; Wang L; Liu Z; Guo X; Jiang Y; Lu Y; Peng Y; Liu T; Yang B; Shan H; Zhang Y; Xu C
    J Mol Cell Cardiol; 2016 Oct; 99():207-217. PubMed ID: 27565029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy.
    Ucar A; Gupta SK; Fiedler J; Erikci E; Kardasinski M; Batkai S; Dangwal S; Kumarswamy R; Bang C; Holzmann A; Remke J; Caprio M; Jentzsch C; Engelhardt S; Geisendorf S; Glas C; Hofmann TG; Nessling M; Richter K; Schiffer M; Carrier L; Napp LC; Bauersachs J; Chowdhury K; Thum T
    Nat Commun; 2012; 3():1078. PubMed ID: 23011132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-199-sponge transgenic mice develop physiological cardiac hypertrophy.
    Li Z; Liu L; Hou N; Song Y; An X; Zhang Y; Yang X; Wang J
    Cardiovasc Res; 2016 May; 110(2):258-67. PubMed ID: 26976621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac hypertrophy and dysfunction induced by overexpression of miR-214 in vivo.
    Yang T; Gu H; Chen X; Fu S; Wang C; Xu H; Feng Q; Ni Y
    J Surg Res; 2014 Dec; 192(2):317-25. PubMed ID: 25085702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-150 Protects Against Pressure Overload-Induced Cardiac Hypertrophy.
    Liu W; Liu Y; Zhang Y; Zhu X; Zhang R; Guan L; Tang Q; Jiang H; Huang C; Huang H
    J Cell Biochem; 2015 Oct; 116(10):2166-76. PubMed ID: 25639779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac hypertrophy is negatively regulated by miR-541.
    Liu F; Li N; Long B; Fan YY; Liu CY; Zhou QY; Murtaza I; Wang K; Li PF
    Cell Death Dis; 2014 Apr; 5(4):e1171. PubMed ID: 24722296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of catalase and oxidative modification of protein kinase CK2 lead to the failure of apoptosis repressor with caspase recruitment domain to inhibit cardiomyocyte hypertrophy.
    Murtaza I; Wang HX; Feng X; Alenina N; Bader M; Prabhakar BS; Li PF
    J Biol Chem; 2008 Mar; 283(10):5996-6004. PubMed ID: 18171680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-222 inhibits pathological cardiac hypertrophy and heart failure.
    Liu X; Li H; Hastings MH; Xiao C; Damilano F; Platt C; Lerchenmüller C; Zhu H; Wei XP; Yeri A; Most P; Rosenzweig A
    Cardiovasc Res; 2024 Mar; 120(3):262-272. PubMed ID: 38084908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA CHRF facilitates cardiac hypertrophy through regulating Akt3 via miR-93.
    Wo Y; Guo J; Li P; Yang H; Wo J
    Cardiovasc Pathol; 2018; 35():29-36. PubMed ID: 29747050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptotagmin-7 mediates cardiac hypertrophy by targeting autophagy.
    Sun T; Han Y; Li JL; Wang S; Jing ZJ; Yan Z; Zhou L; Zuo L; Yang JL; Cao JM
    FEBS J; 2024 Feb; 291(3):489-509. PubMed ID: 37724442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-221 promotes cardiac hypertrophy in vitro through the modulation of p27 expression.
    Wang C; Wang S; Zhao P; Wang X; Wang J; Wang Y; Song L; Zou Y; Hui R
    J Cell Biochem; 2012 Jun; 113(6):2040-6. PubMed ID: 22275134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy.
    Dong DL; Chen C; Huo R; Wang N; Li Z; Tu YJ; Hu JT; Chu X; Huang W; Yang BF
    Hypertension; 2010 Apr; 55(4):946-52. PubMed ID: 20177001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA MIAT enhances cardiac hypertrophy partly through sponging miR-150.
    Zhu XH; Yuan YX; Rao SL; Wang P
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3653-60. PubMed ID: 27649667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.